Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity. JOC 2025, 24 (8s), 343-351. https://doi.org/10.64149/J.Carcinog.24.8s.343-351.